SPAC144.16 Antibody is a rabbit-derived polyclonal antibody raised against the Schizosaccharomyces pombe SPAC144.16 protein. The target protein is annotated as a sister chromatid cohesion protein (predicted) and belongs to the MIP18 family, which is implicated in chromosomal segregation and genome stability .
| Key Target Attributes | Details |
|---|---|
| Gene Name | SPAC144.16 |
| Protein Family | MIP18 family |
| Biological Function | Sister chromatid cohesion (predicted) |
| Organism Specificity | Schizosaccharomyces pombe (strain 972/24843) |
| Protein Structure | Predicted molecular weight: ~72 kDa (unconfirmed) |
The antibody is available in two formats: polyclonal and recombinant.
Host/Reactivity: Rabbit immunoglobulin G (IgG) raised against Schizosaccharomyces pombe .
Purification: Antigen-affinity purification ensures high specificity .
Applications:
Chromosome Dynamics: Used to study sister chromatid cohesion mechanisms in fission yeast, a model organism for eukaryotic cell cycle research .
Protein Localization: Facilitates subcellular localization studies via immunofluorescence .
Functional Genomics: Supports CRISPR/Cas9-based knockout validation by confirming protein absence .
| Parameter | Polyclonal (Rabbit) | Recombinant |
|---|---|---|
| Specificity | High (antigen-affinity) | High (sequence-verified) |
| Production Time | 3–4 months | 2–3 weeks (expression-optimized) |
| Cost | Moderate | High |
| Batch Consistency | Variable | High |
Cross-Reactivity: Validated exclusively for Schizosaccharomyces pombe; no cross-reactivity with human or murine proteins reported .
Sensitivity: Detects endogenous SPAC144.16 at concentrations as low as 0.1 µg/mL in WB .
Species Restriction: Limited to fission yeast applications; not validated for hybridoma generation or in vivo models .
Epitope Mapping: No linear or conformational epitope data available, necessitating empirical optimization for novel assays .
Structural Studies: Recombinant SPAC144.16 could enable cryo-EM or X-ray crystallography to resolve its role in cohesion .
Functional Knockdown: siRNA/CRISPR paired with this antibody may elucidate pleiotropic roles in genome stability.
Comparative Genomics: Investigate MIP18 family conservation across eukaryotes to identify conserved functional domains.
KEGG: spo:SPAC144.16
STRING: 4896.SPAC144.16.1
SPAC144.16 is a gene encoding a MIP18 family protein in Schizosaccharomyces pombe (fission yeast) . The protein is predicted to function as a sister chromatid cohesion protein, suggesting its involvement in chromosome segregation during cell division . As a member of the MIP18 family, it likely plays a role in genomic stability and DNA replication processes. Understanding this protein's function provides critical context for experimental design when using antibodies against it in research settings.
Currently, researchers can access polyclonal antibodies against SPAC144.16, specifically Rabbit anti-Schizosaccharomyces pombe (strain 972/24843) SPAC144.16 Polyclonal Antibody . These antibodies are typically produced through antigen-affinity purification methods and are available in IgG isotype formats. Additionally, recombinant Schizosaccharomyces pombe MIP18 family protein C144.16 (SPAC144.16) is available, which can be used for antibody production or as positive controls in experiments .
SPAC144.16 antibodies have been validated for the following applications:
| Application | Validated | Recommended Dilution |
|---|---|---|
| Western Blot (WB) | Yes | Optimize for specific lot |
| ELISA (EIA) | Yes | Optimize for specific lot |
| Immunofluorescence | Not specified | Requires optimization |
| Immunoprecipitation | Not specified | Requires optimization |
These antibodies are specifically designed to ensure proper identification of the antigen in experimental settings . When designing experiments, researchers should conduct preliminary validation studies to determine optimal working concentrations for their specific experimental conditions.
Methodologically sound validation of SPAC144.16 antibodies should include:
Specificity testing: Compare staining/reactivity between wild-type yeast and SPAC144.16 knockout strains (if available).
Positive controls: Include recombinant SPAC144.16 protein (≥85% purity as determined by SDS-PAGE) as a positive control .
Cross-reactivity assessment: Test the antibody against related proteins to ensure specificity.
Technical validation: For each application (WB, ELISA, etc.), determine optimal concentrations, incubation times, and buffer conditions.
Reproducibility testing: Perform replicate experiments across different biological samples.
For optimal detection of SPAC144.16 in Schizosaccharomyces pombe samples:
Cell lysis: Use gentle lysis methods (such as spheroplasting followed by detergent treatment) to preserve protein structure.
Buffer selection: Choose buffers containing phosphatase and protease inhibitors to prevent degradation.
Subcellular fractionation: Consider nuclear isolation techniques, as SPAC144.16 is predicted to function in sister chromatid cohesion (nuclear process) .
Sample concentration: For low-abundance detection, consider immunoprecipitation prior to Western blotting.
Fixation for microscopy: If performing immunofluorescence, optimize fixation conditions (paraformaldehyde vs. methanol) to maintain epitope accessibility.
These preparation steps are crucial for maintaining protein integrity and ensuring accurate detection of target proteins in complex biological samples.
Applying computational modeling to enhance SPAC144.16 antibody specificity involves:
Structural analysis: If the three-dimensional structure of SPAC144.16 is available, use it to identify unique epitopes for antibody targeting.
Rational design approaches: Implement methods similar to those used for other antibodies, which typically focus on:
Machine learning prediction: Utilize machine learning approaches to predict mutations that might increase binding affinity to SPAC144.16 .
Interface geometry optimization: Analyze and optimize the geometry of the antigen-antibody interface to improve binding kinetics .
These computational approaches can help increase antibody affinity by 2-fold or more, particularly in scenarios where binding to homologous proteins from different species or subtypes is required .
Development of single-chain antibody fragments (scFv) against SPAC144.16 involves:
Template selection: Begin with plasmid DNA encoding existing antibodies against SPAC144.16 .
Mutagenesis by PCR: Use high-fidelity Phusion DNA polymerase and oligonucleotides containing desired mutations to generate variants .
Overlap extension PCR: Join DNA fragments to form complete scFv-encoding sequences (approximately 900 bp) .
Expression and purification: Express constructs in suitable systems (bacterial, yeast, or mammalian) and purify using affinity tags.
Affinity screening: Test multiple variants to identify those with improved binding characteristics.
This approach allows for the generation of smaller, more easily manipulated antibody formats while maintaining specificity for SPAC144.16. The resulting scFv constructs may provide advantages for certain applications requiring tissue penetration or intracellular targeting.
SPAC144.16 antibodies can facilitate chromatin regulation studies through:
Chromatin Immunoprecipitation (ChIP): Identify genomic regions where SPAC144.16 binds, particularly during chromosome replication and segregation.
Co-immunoprecipitation (Co-IP): Determine protein interaction partners of SPAC144.16 within chromatin regulation complexes.
Immunofluorescence microscopy: Track SPAC144.16 localization throughout the cell cycle, particularly during mitosis when sister chromatid cohesion is critical.
Proximity labeling: Combine antibodies with proximity labeling techniques (BioID, APEX) to identify the protein neighborhood of SPAC144.16.
These approaches can provide insights into how SPAC144.16 contributes to gene silencing and chromosomal organization, similar to how Speckled Protein (SP) family proteins function as chromatin readers in mammalian systems . Understanding these mechanisms in yeast could provide evolutionary context for chromatin regulation across species.
When troubleshooting inconsistent results with SPAC144.16 antibodies, consider:
Antibody degradation: Ensure proper storage conditions and avoid repeated freeze-thaw cycles.
Epitope masking: Post-translational modifications or protein interactions may block antibody access to the epitope.
Specificity issues: Confirm the antibody's specificity through appropriate controls, particularly in experiments with related proteins.
Technical variables: Standardize incubation times, temperatures, and buffer compositions across experiments.
Cell cycle dependence: As a predicted sister chromatid cohesion protein, SPAC144.16 levels and localization likely vary throughout the cell cycle . Synchronize cultures when comparing experimental conditions.
Systematic evaluation of these factors will help identify sources of variability and establish more reproducible experimental protocols.
When facing contradictions between antibody-based results and genetic analyses:
Verify antibody specificity: Use SPAC144.16 knockout strains as negative controls to confirm antibody specificity.
Consider protein isoforms: Check if alternative splicing creates protein variants not affected by genetic modifications.
Evaluate assay limitations: Assess whether the detection method has appropriate sensitivity and specificity for the experimental context.
Examine post-transcriptional regulation: Investigate whether discrepancies result from differences between mRNA and protein levels due to post-transcriptional control.
Cross-validate findings: Use orthogonal approaches (e.g., tagged SPAC144.16 constructs) to resolve contradictions.
These analytical approaches help reconcile seemingly contradictory results, potentially revealing important biological insights about SPAC144.16 regulation and function.
For successful immunofluorescence microscopy with SPAC144.16 antibodies:
Fixation optimization: Test multiple fixation methods (paraformaldehyde, methanol, combined approaches) to preserve both cellular architecture and epitope accessibility.
Permeabilization balancing: Adjust detergent concentration and exposure time to enable antibody access while maintaining subcellular structure.
Signal amplification: For low-abundance targets, consider signal amplification methods (tyramide signal amplification, secondary antibody kits).
Colocalization controls: Include markers for nuclear envelope, chromatin, and cell cycle phase to interpret SPAC144.16 localization.
Quantification methods: Establish consistent methods for quantifying fluorescence intensity and determining significance thresholds.
These methodological considerations will maximize detection sensitivity while maintaining specificity, enabling accurate visualization of SPAC144.16 in its native cellular context.
When assessing potential cross-reactivity:
Sequence homology analysis: Compare SPAC144.16 sequences across Schizosaccharomyces species and more distant fungi to identify conserved epitopes.
Domain conservation: Evaluate conservation of specific functional domains (MIP18 family domains) that may be targeted by antibodies.
Epitope mapping: Determine which regions of SPAC144.16 are recognized by the antibody and assess their conservation.
Empirical testing: Validate antibody reactivity against proteins from related species through Western blotting or ELISA.
Understanding evolutionary conservation can inform experimental design when studying related proteins in different yeast species and may provide insights into functional conservation of sister chromatid cohesion mechanisms.
SPAC144.16 research in fission yeast provides valuable insights for higher eukaryotic systems:
Evolutionary model: As a predicted sister chromatid cohesion protein, SPAC144.16 may represent an evolutionary precursor to chromatin regulatory proteins in mammals.
Functional conservation: Compare mechanisms between SPAC144.16 and functionally similar proteins in mammals, such as the Speckled Protein (SP) family that acts as chromatin readers .
Simplified system: Fission yeast provides a less complex model for studying fundamental processes of chromosome segregation and cohesion.
Disease relevance: Insights from SPAC144.16 function may inform understanding of human diseases related to chromosome segregation defects or SP family mutations associated with immunological disorders .